Compass Therapeutics Files Definitive Proxy Statement
Ticker: CMPX · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1738021
| Field | Detail |
|---|---|
| Company | Compass Therapeutics, Inc. (CMPX) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
Related Tickers: CTSO
TL;DR
Compass Therapeutics filed its proxy statement for the June 11th shareholder meeting. Get ready to vote!
AI Summary
Compass Therapeutics, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting of stockholders scheduled for June 11, 2025. The filing, under the 1934 Securities Exchange Act, details information for shareholders regarding the company's operations and upcoming votes. The company, previously known as Olivia Ventures, Inc., is incorporated in Delaware and focuses on biological products.
Why It Matters
This filing provides shareholders with crucial information for the upcoming annual meeting, enabling them to make informed decisions on company matters and governance.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently indicate new risks.
Key Numbers
- 001-39696 — SEC File Number (Identifies the company's filing history with the SEC.)
- 25882824 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- Compass Therapeutics, Inc. (company) — Registrant
- June 11, 2025 (date) — Annual Meeting Date
- April 29, 2025 (date) — Filing Date
- Olivia Ventures, Inc. (company) — Former Company Name
- 80 Guest Street, Boston, MA 02135 (address) — Company Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit votes from shareholders for their annual or special meetings, providing detailed information about the matters to be voted upon.
When is the annual meeting of Compass Therapeutics, Inc. stockholders?
The annual meeting of Compass Therapeutics, Inc. stockholders is scheduled for June 11, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed with the SEC on April 29, 2025.
What was Compass Therapeutics, Inc. formerly known as?
Compass Therapeutics, Inc. was formerly known as Olivia Ventures, Inc.
Where is Compass Therapeutics, Inc. located?
Compass Therapeutics, Inc. is located at 80 Guest Street, Boston, MA 02135.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Compass Therapeutics, Inc. (CMPX).